Kymera Therapeutics Newsroom

Oppenheimer Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $56

Futu NewsSep 27 20:31

Kymera Therapeutics Analyst Ratings

BenzingaSep 27 20:19

Oppenheimer Reaffirms Their Buy Rating on Kymera Therapeutics (KYMR)

TipRanksSep 27 19:49

Piper Sandler Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $60

Futu NewsSep 26 08:32

Leerink Partners Initiates Kymera Therapeutics(KYMR.US) With Buy Rating, Announces Target Price $60

Futu NewsSep 9 19:33

Kymera Therapeutics Price Target Announced at $65.00/Share by Wolfe Research

Dow JonesAug 26 18:36

Wolfe Research Upgrades Kymera Therapeutics(KYMR.US) to Buy Rating, Announces Target Price $65

Futu NewsAug 26 18:32

Kymera Therapeutics Analyst Ratings

BenzingaAug 26 18:27

Morgan Stanley Maintains Kymera Therapeutics(KYMR.US) With Hold Rating, Maintains Target Price $45

Futu NewsAug 14 21:31

Kymera Therapeutics Analyst Ratings

BenzingaAug 14 19:58

Morgan Stanley Maintains Kymera Therapeutics(KYMR.US) With Hold Rating, Raises Target Price to $45

Futu NewsAug 14 19:34

Balancing Pipeline Potential and Clinical Risks: Kymera Therapeutics' Strategic Update and Hold Rating

TipRanksAug 14 18:48

Analysts Offer Insights on Healthcare Companies: Illumina (ILMN), Kymera Therapeutics (KYMR) and Viridian Therapeutics (VRDN)

TipRanksAug 14 17:10

Kymera Therapeutics Analyst Ratings

BenzingaAug 13 01:44

Wells Fargo Maintains Equal-Weight on Kymera Therapeutics, Raises Price Target to $38

BenzingaAug 13 01:44

Optimistic Buy Rating for Kymera Therapeutics Amid Promising Clinical Developments

TipRanksAug 8 18:42

Kymera Therapeutics (KYMR) Gets a Buy From TD Cowen

TipRanksAug 8 04:33

Kymera Therapeutics Analyst Ratings

BenzingaJul 11 01:52

Oppenheimer Maintains Outperform on Kymera Therapeutics, Maintains $52 Price Target

BenzingaJul 11 01:50

B. Riley Securities Maintains Neutral on Kymera Therapeutics, Raises Price Target to $36

BenzingaJul 10 02:00